These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2125736)

  • 21. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of clomipramine on prolactin levels--pilot studies.
    Francis AF; Williams P; Williams R; Link J; Cole EN; Hughes D
    Postgrad Med J; 1976; 52(3 suppl):87-92. PubMed ID: 959095
    [No Abstract]   [Full Text] [Related]  

  • 24. Decreased 5-HT-mediated prolactin release in major depression.
    Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ
    Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine response to clomipramine and desipramine--the evidence of partial determination by heredity and sex.
    Filip V; Alda M; David I; Topinka J; Kristofiková Z; Dvoráková J; Sztaniszláv D; Olájos S; Albrecht V
    Neuropsychobiology; 1989; 21(3):111-6. PubMed ID: 2615927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tricyclic antidepressants on human plasma levels of TSH, GH and prolactin.
    Widerlöv E; Wide L; Sjöström R
    Acta Psychiatr Scand; 1978 Nov; 58(5):449-56. PubMed ID: 102115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):166-71. PubMed ID: 12242577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine.
    Kundermann B; Hemmeter-Spernal J; Strate P; Gebhardt S; Huber MT; Krieg JC; Lautenbacher S
    J Psychiatr Res; 2009 Dec; 43(16):1253-61. PubMed ID: 19467668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clomipramine test and subtypes of depression].
    González-Pinto A; López Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; García Godoy MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):303-9. PubMed ID: 9054201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects.
    Jarrett DB; Pollock B; Miewald JM; Kupfer DJ
    Biol Psychiatry; 1991 Jan; 29(1):3-14. PubMed ID: 2001445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis.
    Cordes J; Larisch R; Henning U; Thünker J; Werner C; Orozco G; Mayoral F; Rivas F; Auburger G; Tosch M; Rietschel M; Gaebel W; Müller HW; Klimke A
    Depress Anxiety; 2009; 26(8):E111-9. PubMed ID: 19288582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary neuroendocrine study with buspirone in major depression.
    Moeller FG; Steinberg JL; Fulton M; Kramer G; Petty F
    Neuropsychopharmacology; 1994 Apr; 10(2):75-83. PubMed ID: 8024675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects.
    Ruegg RG; Gilmore J; Ekstrom RD; Corrigan M; Knight B; Tancer M; Leatherman ME; Carson SW; Golden RN
    Biol Psychiatry; 1997 Dec; 42(12):1123-9. PubMed ID: 9426882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma prolactin concentrations in normal subjects and depressive patients following oral clomipramine.
    Jones RB; Luscombe DK; Groom GV
    Postgrad Med J; 1977; 53 Suppl 4():166-71. PubMed ID: 600893
    [No Abstract]   [Full Text] [Related]  

  • 35. Sublingual apomorphine as a neuroendocrine probe.
    Brunerova L; Potockova J; Horacek J; Koprivova H; Rehula M; Andel M
    Psychiatry Res; 2012 Jul; 198(2):297-9. PubMed ID: 22394588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Odom AM; Carson SW; Sethuraman G
    Biol Psychiatry; 1998 Oct; 44(7):562-7. PubMed ID: 9787880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine testing in electroconvulsive therapy.
    Kamil R; Joffe RT
    Psychiatr Clin North Am; 1991 Dec; 14(4):961-70. PubMed ID: 1771157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated corticosteroids as a possible cause of abnormal neuroendocrine function in depressive illness.
    Kendler KS; Davis KL
    Commun Psychopharmacol; 1977; 1(3):183-94. PubMed ID: 414878
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serotonergic function in endogeneity of depression].
    González-Pinto A; López-Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; Elizagárate E; Pérez de Heredia JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):73-8. PubMed ID: 9245192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered prolactin response to clomipramine rechallenge in healthy subjects.
    Gilmore JH; Ruegg RG; Ekstrom RD; Knight B; Carson SW; Mason GA; Golden RN
    Biol Psychiatry; 1993 Dec; 34(12):885-8. PubMed ID: 8110915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.